FUB-JWH-018

Summary

FUB-JWH-018 (also known as FUB-018) is a naphthoylindole-based synthetic cannabinoid, representing a molecular hybrid of JWH-018 and AB-FUBICA or ADB-FUBICA.[1][2]

FUB-JWH-018
Legal status
Legal status
Identifiers
  • (1-(4-Fluorobenzyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone
CAS Number
  • 2365471-45-8 checkY
ChemSpider
  • 34450892
UNII
  • U0Z5KO073G
Chemical and physical data
FormulaC26H18FNO
Molar mass379.434 g·mol−1
3D model (JSmol)
  • Interactive image
  • O=C(C1=CC=CC2=C1C=CC=C2)C3=CN(CC4=CC=C(F)C=C4)C5=CC=CC=C53
  • InChI=1S/C26H18FNO/c27-20-14-12-18(13-15-20)16-28-17-24(22-9-3-4-11-25(22)28)26(29)23-10-5-7-19-6-1-2-8-21(19)23/h1-15,17H,16H2
  • Key:VREQTLWJHFQLEX-UHFFFAOYSA-N

Legal status edit

In the United States, all CB1 receptor agonists of the 3-(1-naphthoyl)indole class such as FUB-JWH-018 are Schedule I Controlled Substances.[3]

As of October 2015 FUB-JWH-018 is a controlled substance in China.[4]

See also edit

References edit

  1. ^ "FUB-JWH 018". Cayman Chemical. Retrieved 8 July 2015.
  2. ^ Lamoureux C (June 2015). "Apport d'un spectromètre UHPLC-HR-Q-TOF pour l'identification des nouvelles substances psychoactives en circulation". Toxicologie Analytique et Clinique. 27 (2): S67. doi:10.1016/j.toxac.2015.03.107.
  3. ^ 21 U.S.C. § 812: Schedules of controlled substances
  4. ^ "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Archived from the original on 1 October 2015. Retrieved 1 October 2015.